[Pro-health prevention in perimenopausal women with regard to estrogen treatment].
According to the latest demographic forecast in Poland is observed the progressive aging of the population with growing population of perimenopausal women. This is a special time in woman's life, in which there are many metabolic changes, neurovegetative symptoms and mental changes. All of them are connected with decreased concentration of sex hormones. Very important in this period are health behaviors, including healthy lifestyle, regular exercises and proper diet. Highly effective in removing menopausal symptoms is hormone replacement therapy. It also prevents the effects of metabolic disorders. This therapy is primary prevention of cardiovascular diseases and osteoporosis, depression, Alzheimer's and Parkinson's disease and urogenital atrophy. It also has to delay the process of aging. Clinical studies of HERS, WHI and MWS caused extreme caution in the use of hormone replacement therapy and distrust for this therapy between doctors and their patients. It is therefore important to establish priorities for action and individualized therapy, depending on the indications and contraindications for its use.
Pomeranian Medical University of Szczecin, Poland: Chair and Department of Public Health.
Maria
M
Jasińska
Pomeranian Medical University of Szczecin, Poland: Department of Gynecology and Urogynecology.
Iwona
I
Szydłowska
Pomeranian Medical University of Szczecin, Poland: Department of Gynecology and Urogynecology.
Agnieszka
A
Brodowska
Pomeranian Medical University of Szczecin, Poland: Department of Gynecology and Urogynecology.
Andrzej
A
Starczewski
D000544:Alzheimer Disease / Q000517:prevention & control; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D000075202:Contraindications; D003863:Depression / Q000517:prevention & control; D015914:Estrogen Replacement Therapy; D005260:Female; D052776:Female Urogenital Diseases / Q000517:prevention & control; D006801:Humans; D010024:Osteoporosis / Q000517:prevention & control; D010300:Parkinson Disease / Q000517:prevention & control; D047648:Perimenopause / Q000187:drug effects*
hormone replacement therapy; menopausal symptoms; perimenopause